Journal Watch · Cell Reports Medicine · 2026

Cross-tissue atlas of mucosa-associated lymphoid tissue lymphomas reveals intratumoral heterogeneity and microenvironmental subtypes.

This study establishes an LME-based classification framework for MALT lymphoma with biological and clinical relevance.

Kang K, Wu Y, Sun X et al.Cell Reports Medicine3 min readPharma relevance 50/100

DOI: 10.1016/j.xcrm.2026.102785PMID: 42066772Study type: cohort / observational clinical study

TL;DR

This study establishes an LME-based classification framework for MALT lymphoma with biological and clinical relevance.

Key findings

  • Single-cell and spatial mapping further reveal distinct cellular compositions and interaction networks across these subtypes, particularly in relation to B cell activation and angiogenesis, suggesting distinct biological states and subtype-specific therapeutic vulnerabilities.
  • This study establishes an LME-based classification framework for MALT lymphoma with biological and clinical relevance.

Numbers at a glance (from the abstract)

n = 89n = 16n = 9

Every figure above is taken verbatim from the abstract below. Check the full text for denominators, confidence intervals and subgroup detail.

What they did

Here, we report a cohort of 89 MALT lymphoma samples from multiple anatomical sites, profiled by bulk (n = 89), single-nucleus (n = 16), and spatial (n = 9) RNA sequencing. Integrative analysis of 120 bulk transcriptomes from our cohort and two independent cohorts, guided by cell-type-resolved signatures derived from single-nucleus data, identifies three LME subtypes: mesenchymal, inflammatory, and depleted.

Full abstract (original)

Background: Mucosa-associated lymphoid tissue (MALT) lymphoma, a common primary extranodal B cell lymphoma that arises in diverse mucosal tissues, has a pathogenesis closely linked to the supportive lymphoma microenvironment (LME). However, its microenvironmental heterogeneity and therapeutic implications remain unclear.

What they did: Here, we report a cohort of 89 MALT lymphoma samples from multiple anatomical sites, profiled by bulk (n = 89), single-nucleus (n = 16), and spatial (n = 9) RNA sequencing. Integrative analysis of 120 bulk transcriptomes from our cohort and two independent cohorts, guided by cell-type-resolved signatures derived from single-nucleus data, identifies three LME subtypes: mesenchymal, inflammatory, and depleted.

Results & conclusions: Single-cell and spatial mapping further reveal distinct cellular compositions and interaction networks across these subtypes, particularly in relation to B cell activation and angiogenesis, suggesting distinct biological states and subtype-specific therapeutic vulnerabilities. This study establishes an LME-based classification framework for MALT lymphoma with biological and clinical relevance.

Abstract © the authors / Cell Reports Medicine (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1016/j.xcrm.2026.102785 · PubMed 42066772.

Why it matters for pharma & biotech

  • Relevant to General & Medicine teams tracking Cell Reports Medicine for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.

Frequently asked questions

What did this Cell Reports Medicine study find?

This study establishes an LME-based classification framework for MALT lymphoma with biological and clinical relevance.

What type of study is this?

It is a cohort / observational clinical study, published in Cell Reports Medicine in 2026. Here, we report a cohort of 89 MALT lymphoma samples from multiple anatomical sites, profiled by bulk (n = 89), single-nucleus (n = 16), and spatial (n = 9) RNA sequencing.

Where can I read the original paper?

The original is at the publisher via DOI 10.1016/j.xcrm.2026.102785. PubMed ID: 42066772. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Kang K, Wu Y, Sun X et al.. Cross-tissue atlas of mucosa-associated lymphoid tissue lymphomas reveals intratumoral heterogeneity and microenvironmental subtypes.. Cell Reports Medicine (2026). DOI: 10.1016/j.xcrm.2026.102785.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/cross-tissue-atlas-of-mucosa-associated-lymphoid-tissue-lymphomas-reveal-102785/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides